Brain-stimulation therapy at home reduces major depression symptoms

This study highlights the efficacy of home-based tDCS in treating major depressive disorder, with significant improvements in depressive symptoms and remission.

Boehringer’s deal spree; Praxis’ licensing pact with Shanghai biotech; Vico Therapeutics raises $60M

Plus, news about PolyPid, Clarametyx Biosciences, Debiopharm, Repare Therapeutics, Immunic, Voyager Therapeutics, Kymera Therapeutics and Catalyst Pharmaceuticals: Boehringer Ingelheim inks its third deal this week:

January 6, 2024

Cell Signaling Technology and Beyond Benign collaborate to advance green chemistry education

Cell Signaling Technology (CST), a life science discovery technology company and leading provider of antibodies, kits, and services, today announced a partnership with global green

September 20, 2023

CorroHealth Secures Strategic Investment from Patient Square Capital

What You Should Know: – CorroHealth, a leading provider of revenue cycle management (RCM) solutions to health systems and health plans, announced it has signed definitive

October 25, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.